Brief ReportsINTRAVITREAL TRIAMCINOLONE ACETONIDE FOR TREATMENT OF CYSTOID MACULAR EDEMA ASSOCIATED WITH RETINITIS PIGMENTOSAKIM, JUDY E. MDAuthor Information From The Eye Institute, Medical College of Wisconsin, Milwaukee. Supported in part by an unrestricted grant from Research to Prevent Blindness, Inc., New York, New York. Propriety interest: None. Reprint requests: Judy E. Kim, MD, The Eye Institute, Medical College of WI, 925 N. 87th Street, Milwaukee, WI 53226; e-mail: [email protected] RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length; no more than 5 references should be cited; and each Brief Report should include no more than 4 figures. Retina: November 2006 - Volume 26 - Issue 9 - p 1094-1096 doi: 10.1097/01.iae.0000254897.86389.a5 Buy Metrics In Brief Intravitreal triamcinolone acetonide injection can be considered as a treatment option in refractory cystoid macular edema associated with retinitis pigmentosa. However, repeated treatments may be required. © The Ophthalmic Communications Society, Inc.